- Home
- PYPD vs ANGH Comparison
PYPD vs ANGH Comparison
Compare PYPD & ANGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- ANGH
- Stock Information
- Founded
- PYPD 2008
- ANGH 2012
- Country
- PYPD Israel
- ANGH United Arab Emirates
- Employees
- PYPD N/A
- ANGH N/A
- Industry
- PYPD Medical/Dental Instruments
- ANGH Telecommunications Equipment
- Sector
- PYPD Health Care
- ANGH Consumer Discretionary
- Exchange
- PYPD Nasdaq
- ANGH Nasdaq
- Market Cap
- PYPD 34.8M
- ANGH 32.1M
- IPO Year
- PYPD 2020
- ANGH N/A
- Fundamental
- Price
- PYPD $3.19
- ANGH $3.31
- Analyst Decision
- PYPD Strong Buy
- ANGH
- Analyst Count
- PYPD 5
- ANGH 0
- Target Price
- PYPD $11.40
- ANGH N/A
- AVG Volume (30 Days)
- PYPD 114.4K
- ANGH 298.9K
- Earning Date
- PYPD 08-13-2025
- ANGH 08-12-2025
- Dividend Yield
- PYPD N/A
- ANGH N/A
- EPS Growth
- PYPD N/A
- ANGH N/A
- EPS
- PYPD N/A
- ANGH N/A
- Revenue
- PYPD N/A
- ANGH $78,093,405.00
- Revenue This Year
- PYPD N/A
- ANGH N/A
- Revenue Next Year
- PYPD N/A
- ANGH N/A
- P/E Ratio
- PYPD N/A
- ANGH N/A
- Revenue Growth
- PYPD N/A
- ANGH 88.72
- 52 Week Low
- PYPD $2.30
- ANGH $2.53
- 52 Week High
- PYPD $3.93
- ANGH $9.46
- Technical
- Relative Strength Index (RSI)
- PYPD 40.57
- ANGH 40.49
- Support Level
- PYPD $3.07
- ANGH $3.24
- Resistance Level
- PYPD $3.60
- ANGH $3.97
- Average True Range (ATR)
- PYPD 0.18
- ANGH 0.73
- MACD
- PYPD -0.05
- ANGH -0.13
- Stochastic Oscillator
- PYPD 23.81
- ANGH 20.58
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About ANGH Anghami Inc.
Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. It generates the majority of its revenue from subscriptions.